[1]
Pradelli, L. et al. 2014. The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban. Farmeconomia. Health economics and therapeutic pathways. 15, 1S (Dec. 2014), 3–4. DOI:https://doi.org/10.7175/fe.v15i1s.972.